CASEY VIERA: Open Payments
NPI 1144641556 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,401 in 44 payments from 16 companies in 2025. Trend: 2023 $3,849 · 2024 $4,241 · 2025 $2,401
Travel & lodging: $1,275Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. | 19 | $1,686 |
| ABBVIE INC. | 6 | $226 |
| UCB, Inc. | 2 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $63 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| GENZYME CORPORATION | 1 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Botanix SB Inc | 1 | $26 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
Products named: RINVOQ, DUPIXENT, Bimzelx, SKYRIZI, Sotyktu, COSENTYX, SPEVIGO, Rhapsido.
Industry payments across FL — which companies pay providers there.
